COPD and Asthma Devices Market to Reach $41,355.2 Million, Globally, by 2022

Portland, OR -- (SBWire) -- 02/22/2018 --Global COPD and asthma devices market is expected to reach $41,355.2 million by 2022, according to a new report by Allied Market Research . The drug powder inhaler was the highest revenue-generating segment, accounting for over half of the share in 2015. This segment is expected to maintain its dominance throughout the forecast period.

Get PDF Brochure For Details: https://www.alliedmarketresearch.com/request-sample/579

The factors hampering the market growth include environmental concerns associated with metered dose inhalers (MDI) and high cost of selected inhalation devices. Regulatory authorities such as U.S. food and drug administration (USFDA) across several regions have banned the production and sales of MDIs, as they release environmentally hazardous gases such as chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA). Thus, soft mist inhalers (SMIs) and nebulizers are expected to replace MDIs for the treatment of respiratory diseases in the near future.

The key players in the market face price competition from the local device manufacturers. In the developing and underdeveloped regions, the local manufacturers sell these COPD and asthma devices at lower prices owing to the availability of cheap raw materials, thus restraining growth of the market (in terms of value). COPD and asthma treatment is a long and expensive process; affordability of the treatment cost is a core-restraining factor for seeking treatment (services and products/devices). Reimbursements are unavailable or inadequate in many of the developing and underdeveloped nations. Rising percentage of smokers is expected to significantly affect the adoption of these devices by 2020. Portable devices are the only alternative for nebulizer treatments in COPD and asthma.

Enquiry About Report: https://www.alliedmarketresearch.com/purchase-enquiry/579

Compressor nebulizers constitute around four-fifths share of the overall nebulizers market, owing to their perpetual usage in home healthcare medication and widespread availability across various regions. Nebulizers are electric- or battery-powered machines, which dispense the medication in the form of fine mist. They are used in home healthcare set-ups for debilitated patients, geriatric, and children. However, the large size of nebulizers and the need for continuous power supply are expected to hinder the market growth.

COPD AND ASTHMA DEVICES MARKET SEGMENTATION

BY PRODUCT TYPE

Inhalers
Drug Powder Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Soft Mist Inhalers (SMIs)
Nebulizers
Compressor Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers

Buy Now (Report on Discount): https://www.alliedmarketresearch.com/checkout/527018